Despite the disappointing results, the potential of IL-17 antagonists in the treatment of lupus nephritis (LN) cannot be entirely dismissed, given the strong association between IL-17 and SLE/LN as well as encouraging findings from multiple case reports. Here, IL17A is linked to lupus nephritis.